GENE ONLINE|News &
ASGCT21 Highlights: Present Trends and Future Directions of Gene and Cell Therapies in Immuno-Oncology
During the virtual ASGCT meeting, experts reflected on the current trends and future directions of gene and cell therapies in immuno-oncology.
Engineering T Cells to Better Recognize Cancer Cells
Current immune checkpoint therapies try to release the breaks of the T cells to fight cancer. Most of these therapies target either CTLA-4, which prevents T cell activation at the lymph nodes or PD-1/PD-L1, which downregulates T cell activity in the tumor microenvironment.
Engineering T Cells to Better Recognize Cancer Cells
Current immune checkpoint therapies try to release the breaks of the T cells to fight cancer. Most of these therapies target either CTLA-4, which prevents T cell activation at the lymph nodes or PD-1/PD-L1, which downregulates T cell activity in the tumor microenvironment.
GO Prime with only $1.49 now
LATEST
Blinatumomab Linked to Epstein-Barr Virus Reactivation in Pre-Allogeneic Stem Cell Transplant Patients
2026-01-23
Unified Framework Combining U-Net++ and CNN-RNN-BiGRU Developed for Automated Weed Detection in Agriculture
2026-01-23
Study Explores Use of EHR Portals for Collecting Advance Directives and Surrogate Information
2026-01-23
Study Finds High Turnover Intentions Among Nurses in Tertiary Care Settings Due to Workplace Stress and Limited Career Growth
2026-01-23
